Published in
Elsevier, European Journal of Cancer, (160), p. 287-288, 2022
DOI: 10.1016/j.ejca.2021.10.002
Links
Tools
Corrigendum to ‘Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)’ [European Journal of Cancer 152 (2021) 116-128]
Journal article published in 2022 by
Helen Gogas,
Reinhard Dummer,
Paolo A. Ascierto,
Ana Arance,
Mario Mandalà,
Gabriella Liszkay,
Claus Garbe,
Dirk Schadendorf,
Ivana Krajsová,
Ralf Gutzmer,
Vanna Chiarion Sileni 
,
Caroline Dutriaux,
Naoya Yamazaki,
Carmen Loquai,
Paola Queirolo
and other authors.
,
Caroline Dutriaux,
Naoya Yamazaki,
Carmen Loquai,
Paola Queirolo
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 